KENDRA CONSIDINE: Open Payments
NPI 1609588110 · OAK BROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,869 in 221 payments from 17 companies in 2025. Trend: 2023 $1,651 · 2024 $1,851 · 2025 $19,869
Speaker / faculty: $6,432Food & beverage: $6,374Consulting: $3,840Travel & lodging: $3,223
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 36 | $14,718 |
| Alkermes, Inc. | 20 | $791 |
| Otsuka America Pharmaceutical, Inc. | 22 | $667 |
| Teva Pharmaceuticals USA, Inc. | 23 | $653 |
| ABBVIE INC. | 28 | $551 |
| Neurocrine BioSciences, Inc. | 15 | $442 |
| Tris Pharma Inc | 11 | $389 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $364 |
| Vanda Pharmaceuticals Inc. | 10 | $309 |
| Lundbeck LLC | 13 | $299 |
Products named: COBENFY, VRAYLAR, LYBALVI, REXULTI, INGREZZA, CAPLYTA, AUSTEDO XR, Dyanavel XR.
Industry payments across IL — which companies pay providers there.
